Seres Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Seres Therapeutics, Inc. (MCRB) reported Increase (Decrease) in Accounts Payable of -$496.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.15M, a 1558.23% decline year-over-year.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $656.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $5.00K.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$515.00K, a 1455.26% decline year-over-year.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$2.40M.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$2.94M.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$11.58M, a 625.56% decline from fiscal 2022.
- Seres Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was $2.20M, a 76.47% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$496.00K 10-Q · filed 2026-08-05 | -$491.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $656.00K 10-Q · filed 2026-05-05 | $661.00K derived: sum of 2 quarters · filed 2026-05-05 | $146.00K derived: sum of 3 quarters · filed 2026-05-05 | $225.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$510.00K derived: sum of 2 quarters · filed 2026-03-12 | -$431.00K derived: sum of 3 quarters · filed 2026-08-05 | -$2.40M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$515.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$436.00K derived: sum of 2 quarters · filed 2026-08-05 | -$2.40M 10-Q · filed 2025-11-05 | -$6.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.89M 10-Q · filed 2026-08-05 | -$6.05M derived: sum of 3 quarters · filed 2026-08-05 | -$6.01M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.97M 10-Q · filed 2026-05-05 | -$6.13M derived: sum of 2 quarters · filed 2026-05-05 | -$6.09M derived: sum of 3 quarters · filed 2026-05-05 | -$6.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$4.12M derived: sum of 2 quarters · filed 2026-03-12 | -$4.53M derived: sum of 3 quarters · filed 2026-03-12 | -$2.94M 10-K · filed 2026-03-12 |
| 2024-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$372.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.22M 10-Q · filed 2025-11-05 | -$3.82M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$410.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.18M 10-Q · filed 2025-08-06 | -$3.85M derived: sum of 3 quarters · filed 2026-03-12 | -$7.30M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $1.59M 10-Q · filed 2025-05-07 | -$3.44M derived: sum of 2 quarters · filed 2026-03-12 | -$6.89M derived: sum of 3 quarters · filed 2026-03-12 | -$6.18M derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -$5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$8.49M derived: sum of 2 quarters · filed 2026-03-12 | -$7.77M derived: sum of 3 quarters · filed 2026-03-12 | -$11.58M 10-K · filed 2026-03-12 |
| 2023-09-30 | -$3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$2.73M derived: sum of 2 quarters · filed 2024-11-13 | -$6.54M 10-Q · filed 2024-11-13 | -$1.09M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | $714.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$3.09M 10-Q · filed 2024-08-13 | $2.36M derived: sum of 3 quarters · filed 2025-03-13 | -$1.60M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | -$3.81M 10-Q · filed 2024-05-08 | $1.65M derived: sum of 2 quarters · filed 2025-03-13 | -$2.31M derived: sum of 3 quarters · filed 2025-03-13 | $4.86M derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.49M derived: sum of 2 quarters · filed 2025-03-13 | $8.67M derived: sum of 3 quarters · filed 2025-03-13 | $2.20M 10-K · filed 2025-03-13 |
| 2022-09-30 | -$3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.21M derived: sum of 2 quarters · filed 2023-11-02 | -$3.25M 10-Q · filed 2023-11-02 | $1.33M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $7.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $709.00K 10-Q · filed 2023-08-08 | $5.29M derived: sum of 3 quarters · filed 2024-03-05 | $8.39M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$6.46M 10-Q · filed 2023-05-09 | -$1.88M derived: sum of 2 quarters · filed 2024-03-05 | $1.21M derived: sum of 3 quarters · filed 2024-03-05 | $1.93M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $7.68M derived: sum of 2 quarters · filed 2024-03-05 | $8.39M derived: sum of 3 quarters · filed 2024-03-05 | $9.36M 10-K · filed 2024-03-05 |
| 2021-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $3.81M derived: sum of 2 quarters · filed 2022-11-02 | $4.78M 10-Q · filed 2022-11-02 | $2.59M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $711.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.68M 10-Q · filed 2022-08-03 | -$507.00K derived: sum of 3 quarters · filed 2023-03-07 | $1.23M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $973.00K 10-Q · filed 2022-05-04 | -$1.22M derived: sum of 2 quarters · filed 2023-03-07 | $514.00K derived: sum of 3 quarters · filed 2023-03-07 | -$776.00K derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$459.00K derived: sum of 2 quarters · filed 2023-03-07 | -$1.75M derived: sum of 3 quarters · filed 2023-03-07 | -$1.16M 10-K · filed 2023-03-07 |
| 2020-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $442.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.03M 10-Q · filed 2021-11-10 | $1.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$700.00K 10-Q · filed 2021-08-03 | -$303.00K derived: sum of 3 quarters · filed 2022-03-01 | -$515.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $590.00K 10-Q · filed 2021-05-04 | $987.00K derived: sum of 2 quarters · filed 2022-03-01 | $775.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.60M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $185.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.01M derived: sum of 3 quarters · filed 2022-03-01 | -$1.46M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $617.00K derived: sum of 2 quarters · filed 2020-11-09 | -$1.86M 10-Q · filed 2020-11-09 | -$2.32M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$1.65M 10-Q · filed 2020-07-28 | -$2.10M derived: sum of 3 quarters · filed 2021-03-02 | -$461.00K derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | -$2.47M 10-Q · filed 2020-05-07 | -$2.93M derived: sum of 2 quarters · filed 2021-03-02 | -$1.29M derived: sum of 3 quarters · filed 2021-03-02 | -$1.40M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | -$459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.18M derived: sum of 2 quarters · filed 2021-03-02 | $1.07M derived: sum of 3 quarters · filed 2021-03-02 | -$353.00K 10-K · filed 2021-03-02 |
| 2018-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.53M derived: sum of 2 quarters · filed 2019-11-05 | $106.00K 10-Q · filed 2019-11-05 | $1.75M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$1.54M 10-Q · filed 2019-08-06 | $109.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.26M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$1.43M 10-Q · filed 2019-05-02 | $220.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.37M derived: sum of 3 quarters · filed 2020-03-02 | -$366.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.79M derived: sum of 2 quarters · filed 2020-03-02 | $1.06M derived: sum of 3 quarters · filed 2020-03-02 | -$856.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$586.00K derived: sum of 2 quarters · filed 2018-11-08 | -$2.50M 10-Q · filed 2018-11-08 | $995.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$3.65M 10-Q · filed 2018-08-02 | -$154.00K derived: sum of 3 quarters · filed 2019-03-06 | -$465.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | -$1.92M 10-Q · filed 2018-05-09 | $1.58M derived: sum of 2 quarters · filed 2019-03-06 | $1.27M derived: sum of 3 quarters · filed 2019-03-06 | $334.00K derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $3.19M derived: sum of 2 quarters · filed 2019-03-06 | $2.25M derived: sum of 3 quarters · filed 2019-03-06 | $3.58M 10-K · filed 2019-03-06 |
| 2016-09-30 | -$311.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$1.25M derived: sum of 2 quarters · filed 2017-11-08 | $84.00K 10-Q · filed 2017-11-08 | $2.23M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | -$936.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $395.00K 10-Q · filed 2017-08-03 | $2.54M derived: sum of 3 quarters · filed 2018-03-08 | $3.22M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $1.33M 10-Q · filed 2017-05-04 | $3.48M derived: sum of 2 quarters · filed 2018-03-08 | $4.15M derived: sum of 3 quarters · filed 2018-03-08 | $4.20M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.82M derived: sum of 2 quarters · filed 2018-03-08 | $2.87M derived: sum of 3 quarters · filed 2018-03-08 | $2.68M 10-K · filed 2018-03-08 |
| 2015-09-30 | $673.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $721.00K derived: sum of 2 quarters · filed 2016-11-10 | $532.00K 10-Q · filed 2016-11-10 | $823.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$141.00K 10-Q · filed 2016-08-11 | $150.00K derived: sum of 3 quarters · filed 2017-03-16 | $545.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$189.00K 10-Q · filed 2016-05-16 | $102.00K derived: sum of 2 quarters · filed 2017-03-16 | $497.00K derived: sum of 3 quarters · filed 2017-03-16 | |
| 2014-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $686.00K derived: sum of 2 quarters · filed 2017-03-16 | $810.00K 10-K · filed 2017-03-16 | |
| 2014-09-30 | $395.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $519.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $124.00K 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $281.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |